PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $325 | -99.9% | 200,499 | -66.0% | 0.00% | -100.0% |
| Q3 2022 | $439,000 | -39.2% | 590,568 | -36.4% | 0.00% | 0.0% |
| Q2 2022 | $722,000 | +32.0% | 929,000 | +53.8% | 0.00% | 0.0% |
| Q1 2022 | $547,000 | -61.2% | 604,181 | +80.2% | 0.00% | -50.0% |
| Q4 2020 | $1,408,000 | +108.6% | 335,300 | +137.8% | 0.00% | +100.0% |
| Q3 2020 | $675,000 | -23.8% | 141,000 | -3.2% | 0.00% | 0.0% |
| Q2 2020 | $886,000 | +336.5% | 145,700 | +293.8% | 0.00% | – |
| Q1 2020 | $203,000 | -75.3% | 37,000 | -55.4% | 0.00% | -100.0% |
| Q4 2019 | $823,000 | +39.7% | 83,000 | -18.9% | 0.00% | – |
| Q3 2019 | $589,000 | +263.6% | 102,300 | +474.7% | 0.00% | – |
| Q2 2019 | $162,000 | -23.6% | 17,800 | +16.3% | 0.00% | – |
| Q1 2019 | $212,000 | +236.5% | 15,300 | +17.7% | 0.00% | – |
| Q2 2016 | $63,000 | -74.3% | 13,000 | -11.5% | 0.00% | -100.0% |
| Q2 2015 | $245,000 | – | 14,697 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |